Tevogen TVGN
NASDAQ TVGN
$6.53 -0.17 (-2.54%)
At close: Oct 23, 2026 · 4:00 PM EDT

Tevogen (TVGN) EBITDA Margin (2024)

Updated

Analysis

Tevogen (TVGN) EBITDA Margin (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 32.68%
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 49.01%
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 6.02%
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn -
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 33.11%
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 46.01%
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -124.26%
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 39.16%
10 Tevogen 27.79 Mn 27.79 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -141,650,616.67%
API Access

Tevogen EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=TVGN&period=max&api_key=YOUR_API_KEY